AMIKACIN SULFATE
AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
Hikma Pharmaceuticals USA
Indication
Pseudomonas aeruginosa peritonitis
*Pseudomonas aeruginosa* peritonitis is a severe, opportunistic intra-abdominal infection of the peritoneum caused by the Gram-negative aerobic bacillus *Pseudomonas aeruginosa*. Read more about Pseudomonas aeruginosa peritonitis
60 drugs 36 manufacturers
Drugs that treat it
Common Pseudomonas aeruginosa peritonitis therapies.
MERREM (meropenem)
MENINGOCOCCAL MENINGITIS·+21
Parke-Davis Pfizer
AMIKACIN (amikacin sulfate)
AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
FRESENIUS KABI
MEROPENEM
MENINGOCOCCAL MENINGITIS·+21
MEITHEAL PHARMA
RECARBRIO (imipenem/cilastatin sodium/relebactam)
BETA-LACTAMS·NOSOCOMIAL BACTERIAL PNEUMONIA·+6
Merck Sharp & Dohme
MEROPENEM
BETA-LACTAMS·MENINGOCOCCAL MENINGITIS·+21
WG CRITICAL CAR
GENTAMICIN SULFATE
AMINOGLYCOSIDES, PARENTERAL·SEPSIS CAUSED BY ENTEROBACTER·+63
EUGIA US LLC
MEROPENEM
BETA-LACTAMS·MENINGOCOCCAL MENINGITIS·+21
XELLIA PHARMACE
MEROPENEM
BETA-LACTAMS·MENINGOCOCCAL MENINGITIS·+21
ARMAS PHARMACEU
Filter & compare in the drug finder →Opens the drug finder with Pseudomonas aeruginosa peritonitis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Pseudomonas aeruginosa* peritonitis is a severe, opportunistic intra-abdominal infection of the peritoneum caused by the Gram-negative aerobic bacillus *Pseudomonas aeruginosa*.
It most commonly arises in vulnerable patient populations, notably individuals undergoing peritoneal dialysis or those who have experienced postoperative abdominal complications, catheter-related biofilm colonization, or prior broad-spectrum antimicrobial exposure.
Clinically, the infection is defined by abdominal pain, tenderness, systemic signs of inflammation, and cloudy peritoneal effluent exhibiting significant neutrophilic pleocytosis.
Pathophysiologically, the organism's intrinsic virulence factors, tendency to form resilient biofilms on indwelling biomaterials, and broad antimicrobial resistance mechanisms make this form of peritonitis notoriously recalcitrant, frequently causing peritoneal membrane damage, catheter loss, and persistent infection.
- nih.gov
*Pseudomonas aeruginosa* peritonitis is a severe, opportunistic intra-abdominal infection of the peritoneum caused by the Gram-negative aerobic bacillus *Pseudomonas aeruginosa* It most commonly arises in vulnerable patient populations, notably individuals undergoing peritoneal dialysis or those who have experienced postoperative abdominal complications, catheter-related biofilm colonization, or prior broad-spectrum antimicrobial exposure Clinically, the infection is defined by abdominal pain, t...
- nih.gov
*Pseudomonas aeruginosa* peritonitis is a severe, opportunistic intra-abdominal infection of the peritoneum caused by the Gram-negative aerobic bacillus *Pseudomonas aeruginosa* Pathophysiologically, the organism's intrinsic virulence factors, tendency to form resilient biofilms on indwelling biomaterials, and broad antimicrobial resistance mechanisms make this form of peritonitis notoriously recalcitrant, frequently causing peritoneal membrane damage, catheter loss, and persistent infection
- nih.gov
It most commonly arises in vulnerable patient populations, notably individuals undergoing peritoneal dialysis or those who have experienced postoperative abdominal complications, catheter-related biofilm colonization, or prior broad-spectrum antimicrobial exposure
- nih.gov
It most commonly arises in vulnerable patient populations, notably individuals undergoing peritoneal dialysis or those who have experienced postoperative abdominal complications, catheter-related biofilm colonization, or prior broad-spectrum antimicrobial exposure
- nih.gov
Clinically, the infection is defined by abdominal pain, tenderness, systemic signs of inflammation, and cloudy peritoneal effluent exhibiting significant neutrophilic pleocytosis
- nih.gov
Pathophysiologically, the organism's intrinsic virulence factors, tendency to form resilient biofilms on indwelling biomaterials, and broad antimicrobial resistance mechanisms make this form of peritonitis notoriously recalcitrant, frequently causing peritoneal membrane damage, catheter loss, and persistent infection
Personalize your experience
Follow Pseudomonas aeruginosa peritonitis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.